For the millions of people living with HIV/AIDS, antiretroviral drugs can be a lifeline, slowing the progress of viral infection. Unfortunately, studies have shown that these benefits can be short-lived: therapy can lead to mutations in the HIV genetic code, which can make the virus resistant to drugs. However, researchers have made some new insight into how the therapy functions and how therapy-induced point mutations actually confer drug resistance.